First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials.

MLA

Takyar, Shweta, et al. “First-Line Therapy for Treatment-Naive Patients with Advanced/Metastatic Renal Cell Carcinoma: A Systematic Review of Published Randomized Controlled Trials.” Anti-Cancer Drugs, vol. 27, no. 5, June 2016, pp. 383–97. EBSCOhost, https://doi.org/10.1097/CAD.0000000000000335.

APA

Takyar, S., Diaz, J., Sehgal, M., Sapunar, F., & Pandha, H. (2016). First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials. Anti-Cancer Drugs, 27(5), 383–397. https://doi.org/10.1097/CAD.0000000000000335

Chicago

Takyar, Shweta, Jose Diaz, Manu Sehgal, Francisco Sapunar, and Hardev Pandha. 2016. “First-Line Therapy for Treatment-Naive Patients with Advanced/Metastatic Renal Cell Carcinoma: A Systematic Review of Published Randomized Controlled Trials.” Anti-Cancer Drugs 27 (5): 383–97. doi:10.1097/CAD.0000000000000335.